[go: up one dir, main page]

MX2014007300A - Composiciones farmaceuticas topicas que comprenden bexaroteno y corticosteroides. - Google Patents

Composiciones farmaceuticas topicas que comprenden bexaroteno y corticosteroides.

Info

Publication number
MX2014007300A
MX2014007300A MX2014007300A MX2014007300A MX2014007300A MX 2014007300 A MX2014007300 A MX 2014007300A MX 2014007300 A MX2014007300 A MX 2014007300A MX 2014007300 A MX2014007300 A MX 2014007300A MX 2014007300 A MX2014007300 A MX 2014007300A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
corticosteroids
include bexarotene
topic
topic pharmaceutical
Prior art date
Application number
MX2014007300A
Other languages
English (en)
Inventor
Fritjof Evers
Henning Mallwitz
Christoph Willers
Sabine Fielhauer
Hagen Trommer
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48781060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014007300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP12000077.3A external-priority patent/EP2612665A1/en
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of MX2014007300A publication Critical patent/MX2014007300A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen composiciones farmacéuticas tópicas que comprenden: a) bexaroteno, b) un corticosteroide, y c) un portador o vehículo. Dichas composiciones son útiles para el tratamiento de trastornos de la piel.
MX2014007300A 2012-01-09 2012-12-18 Composiciones farmaceuticas topicas que comprenden bexaroteno y corticosteroides. MX2014007300A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12000077.3A EP2612665A1 (en) 2012-01-09 2012-01-09 Topical pharmaceutical compositions comprising bexarotene and a corticosteroide
US201261585786P 2012-01-12 2012-01-12
US201261598095P 2012-02-13 2012-02-13
EP12000909 2012-02-13
PCT/EP2012/005237 WO2013104399A1 (en) 2012-01-09 2012-12-18 Topical pharmaceutical compositions comprising bexarotene and a corticosteroids

Publications (1)

Publication Number Publication Date
MX2014007300A true MX2014007300A (es) 2014-07-28

Family

ID=48781060

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007300A MX2014007300A (es) 2012-01-09 2012-12-18 Composiciones farmaceuticas topicas que comprenden bexaroteno y corticosteroides.

Country Status (21)

Country Link
US (1) US20140349981A1 (es)
EP (1) EP2802321A1 (es)
JP (1) JP2015503573A (es)
KR (1) KR20140107370A (es)
CN (1) CN104053437A (es)
AU (1) AU2012365658A1 (es)
BR (1) BR112014015578A8 (es)
CA (1) CA2857207A1 (es)
CL (1) CL2014001776A1 (es)
CO (1) CO7000772A2 (es)
CR (1) CR20140326A (es)
EA (1) EA201400806A1 (es)
GT (1) GT201400146A (es)
HK (1) HK1198423A1 (es)
IL (1) IL232765A0 (es)
MX (1) MX2014007300A (es)
PE (1) PE20142375A1 (es)
PH (1) PH12014501573A1 (es)
SG (1) SG11201403762PA (es)
WO (1) WO2013104399A1 (es)
ZA (1) ZA201403483B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3044216B1 (en) 2013-08-20 2022-02-23 University of Washington through its Center for Commercialization Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydroxylase
AU2016279801B2 (en) 2015-06-18 2021-09-09 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
JP2022508512A (ja) * 2018-09-28 2022-01-19 ジョエル スタディン ステロイド及び巨大分子の経穴送達
BR112021007877A2 (pt) * 2018-10-26 2021-08-03 Viramal Limited composição em gel mucoadesiva

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4387463B2 (ja) 1997-02-20 2009-12-16 アラーガン、インコーポレイテッド タザロテンおよびコルチコステロイドによる乾癬の処置
CN1210034C (zh) * 2002-12-06 2005-07-13 重庆华邦制药股份有限公司 治疗银屑病的药物组合物
CN1210035C (zh) 2003-09-29 2005-07-13 中国医学科学院皮肤病研究所 治疗银屑病的复方外用药物

Also Published As

Publication number Publication date
CA2857207A1 (en) 2013-07-18
GT201400146A (es) 2015-10-12
EP2802321A1 (en) 2014-11-19
PE20142375A1 (es) 2015-01-11
ZA201403483B (en) 2015-06-24
AU2012365658A1 (en) 2014-07-03
CL2014001776A1 (es) 2014-08-29
CN104053437A (zh) 2014-09-17
PH12014501573A1 (en) 2014-10-08
IL232765A0 (en) 2014-07-31
WO2013104399A1 (en) 2013-07-18
EA201400806A1 (ru) 2015-02-27
CO7000772A2 (es) 2014-07-21
HK1198423A1 (zh) 2015-04-24
JP2015503573A (ja) 2015-02-02
BR112014015578A8 (pt) 2017-07-04
CR20140326A (es) 2015-01-16
KR20140107370A (ko) 2014-09-04
SG11201403762PA (en) 2014-07-30
US20140349981A1 (en) 2014-11-27
BR112014015578A2 (pt) 2017-06-13

Similar Documents

Publication Publication Date Title
NI201600071A (es) Compuestos de inhibidor de autotaxina
CL2017003404A1 (es) Compuestos antibacterianos
CL2018002814A1 (es) Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel.
MX384490B (es) Agentes que inducen apoptosis para el tratamiento de cancer y enfermedades inmunitarias y autoinmunitarias.
BR112016023815A2 (pt) composições tópicas para o alívio da dor, produção e uso
ECSP17064695A (es) Compuestos y composiciones de alfa-cinamida como inhibidores de hdac8
MX2019000588A (es) Moduladores de la somatostatina y usos de los mismos.
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
CL2017002719A1 (es) Imidazopirazinonas como inhibidores de pde1
EA201691808A1 (ru) Кортикостероидные композиции для местного применения
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
BR112015023074A2 (pt) agentes de ligação-met e uso dos mesmos
MX376183B (es) Composiciones para el tratamiento de rosacea.
DOP2016000152A (es) Quinazolin-thf-aminas como inhibidores de pde1.
GT201400146A (es) Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides
MX2015009277A (es) Formas de dosificacion y usos terapauticos de l-4-cloro quinurenina.
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
BR112016016901A2 (pt) agentes para o uso no tratamento de inflamação retinal
EA032472B9 (ru) Композиция для укладки волос
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).
PH12020500472A1 (en) Autotaxin inhibitor compounds
BR112015021410A2 (pt) inibidores macrocíclicos das interações das proteína/proteína pd-1/pd-l1 e cd80(b7-1)/pd-l1